Printable version The Global HIV Vaccine Enterprise is a unique, international alliance of independent research, funding, advocacy and stakeholder organizations and governments, engaged in unprecedented collaboration to speed the development of a safe and effective HIV vaccine.
HIV vaccine research has progressed further and faster in the last few years than at any time since the epidemic began. This new and highly promising era in research is a result of the outstanding achievements of Enterprise stakeholders, many of which are reflected in the Enterprise 2008 - 2010 Report of Activities.
| Enterprise Stakeholders Include |
